➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Moodys
Harvard Business School
Merck
Johnson and Johnson

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019855


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 019855 describes ELIMITE, which is a drug marketed by Mylan and is included in one NDA. It is available from two suppliers. Additional details are available on the ELIMITE profile page.

The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the permethrin profile page.
Summary for 019855
Tradename:ELIMITE
Applicant:Mylan
Ingredient:permethrin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019855
Medical Subject Heading (MeSH) Categories for 019855
Suppliers and Packaging for NDA: 019855
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELIMITE permethrin CREAM;TOPICAL 019855 NDA Prestium Pharma, Inc. 40076-230 40076-230-60 1 TUBE in 1 CARTON (40076-230-60) > 60 g in 1 TUBE
ELIMITE permethrin CREAM;TOPICAL 019855 NDA AUTHORIZED GENERIC Renaissance Pharma, Inc. 40085-615 40085-615-60 1 TUBE in 1 CARTON (40085-615-60) > 60 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength5%
Approval Date:Aug 25, 1989TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Moodys
Express Scripts
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.